ARCH Venture Partners
ARCH Venture Partners backs disruptive science companies, providing seed and early-stage venture capital. They focus on revolutionary technologies with the potential to impact people's lives, taking a long-term view and partnering with amazing people to build successful companies.
📥 Buy Full VC Dataset
Offices: Chicago (United States), Seattle (United States), San Francisco (United States)
Investment Stages: Seed, Series A, Series B
Markets: Information Technology, Life Sciences, Physical Sciences
Founded Year: 1986
Investor Type: Venture Capital
Portfolio Companies: Illumina, Juno Therapeutics, Agios Pharmaceuticals, Grail, Twist Bioscience, Vir Biotechnology, Denali Therapeutics, 908 Devices, Accompany Health, Aera Therapeutics, Alnylam Pharmaceuticals, Altos Labs, Arbor Biotechnologies, Areteia Therapeutics, Arsenal Biosciences, Aspen Neuroscience, Autobahn Therapeutics, Basking Biosciences, BE Biopharma, Beam Therapeutics, Bit Bio, Bitterroot Bio, Boundless Bio, Brii Biosciences, Carrick Therapeutics, Chroma Medicine, City Therapeutics, CStone Pharmaceuticals, Curie Bio, Cytrellis Biosystems, Denali Therapeutics, Dewpoint Therapeutics, Dispatch Biotherapeutics, eGenesis, Elephas Biosciences, Encoded Therapeutics, Encodia, Enumerix, EQRx, Erasca, Faraday Pharmaceuticals, Gate Bioscience, Generate Biomedicines, Gossamer Bio, Grail, hC Bioscience, HiberCell, Homeward Health, Hua Medicine, Human Immunology Biosciences, Illumina, Inograft Biotherapeutics, Insitro, Jaguar Gene Therapy, Juno Therapeutics, JUST Biotherapeutics, JW Therapeutics, Karuna Therapeutics, Kisbee Therapeutics, KSQ Therapeutics, Kura Oncology, Kythera Biopharmaceuticals, LifeMine Therapeutics, Lifordi Immunotherapeutics, Lightcast Discovery, Lilac Therapeutics, Lyell Immunopharma, Magnet Biomedicine, Matter Neuroscience, Maze Therapeutics, Metsera, Mirador Therapeutics, Moleculent AB, Moonwalk Biosciences, Mozart Therapeutics, Myeloid Therapeutics, National Resilience, Neumora Therapeutics, Nutcracker Therapeutics, Nvelop Therapeutics, Omniome, OneBioMed, ONI, Orbital Therapeutics, Parabilis Medicines, Paradigm Health, Paratus Sciences, Pheast Therapeutics, Pretzel Therapeutics, Prime Medicine, Protillion Biosciences, Qihan Biotech, Quanterix, Quantum Circuits, Rapport Therapeutics, Reactive Biosciences, Receptos, Recuro Health, Remix Therapeutics, RIPPL Care, ROME Therapeutics, Sana Biotechnology, Scale Biosciences, Scholar Rock, SciNeuro Pharmaceuticals, Seaport Therapeutics, Semma Therapeutics, Singleron Biotechnologies, Singular Genomics Systems, Sironax, Skylark Bio, Slingshot Biosciences, Sonoma Biotherapeutics, SonoThera, Synchron, Tome Biosciences, Transcenta Holding, Treeline Biosciences, Trotana Therapeutics, Twist Bioscience, Ultivue, Unity Biotechnology, VBI Vaccines, Verve Therapeutics, Vesalius Therapeutics, Vilya, Vir Biotechnology, Vividion Therapeutics, Vizgen, Volastra Therapeutics, Walden Biosciences, Xaira Therapeutics
Website: https://www.archventure.com
Team Page: https://www.archventure.com/team/
Portfolio Link: https://www.archventure.com/portfolio/
LinkedIn: https://www.linkedin.com/company/arch-venture-partners
Crunchbase: https://www.crunchbase.com/organization/arch-venture-partners
Comments
No comments yet. Be the first to comment!